Health insurers slide after U.S. proposes nearly flat Medicare Advantage payment update for 2027

U.S. health-insurance stocks sank in early trading on Tuesday after the federal government proposed a much smaller-than-expected increase in Medicare Advantage payments for 2027. The update—released late Monday by the Centers for Medicare & Medicaid Services (CMS)—would raise Medicare Advantage payment rates by just 0.09% on a net average basis, translating to a little over $700 million in additional payments across the program.

The proposal landed as a shock for investors because analysts had been looking for a considerably larger increase—some estimates ran as high as 6%. The gap between expectations and the proposed update immediately pressured shares of companies that rely heavily on Medicare Advantage membership growth and margins, including UnitedHealth, CVS Health, and Humana.

In premarket moves cited in market reports, UnitedHealth was down around 8%, CVS about 9%, and Humana close to 14%. The declines reflected worries that 2027 reimbursement may not keep up with medical-cost trends—especially after insurers have already flagged elevated utilization and cost pressures in recent quarters.

Analysts warned that, if finalized near these levels, the proposed update could force insurers to make difficult trade-offs. Those choices could include reducing benefits, adjusting supplemental offerings, increasing premiums where allowed, tightening provider networks, or even pulling back from certain counties or plan types to protect profitability.

CMS framed the proposal as part of an effort to improve how Medicare Advantage works for beneficiaries and taxpayers, while also continuing changes to risk adjustment that influence how plans are paid when enrollees have higher medical needs. The agency typically reviews industry feedback before issuing a final payment notice later in the year, meaning the 0.09% figure can still change.

Even so, the market reaction underscored how central Medicare Advantage has become to the business models of major insurers. With a large and growing senior population choosing private Medicare plans, small changes in payment policy can ripple quickly through earnings expectations and competitive strategy—especially in a year when political scrutiny of health-care costs remains intense.

The next steps will be shaped by comment letters from insurers and industry groups, plus CMS’s own modeling as it weighs cost trends and the impact of policy adjustments. For now, investors are bracing for a tougher 2027 pricing cycle and the likelihood that plan designs for seniors will face new constraints if reimbursement remains near flat.